Results 171 to 180 of about 161,469 (302)

Clinicopathological and sonographic characterization of NTRK-fusion papillary thyroid carcinoma based on preoperative molecular testing: a comparative study with BRAF^V600E PTC. [PDF]

Front Oncol
Zhang Y, Zou D, Wu X, Han M, Gai J, Ding W, Xu S, Liu C, Wu X, Wang Y.   +9 more
europepmc   +1 more source

Total thyroidectomy without prophylactic central neck dissection in clinically node-negative papillary thyroid cancer: is it an adequate treatment? [PDF]

, 2014
CALO', PIETRO GIORGIO, ERDAS, ENRICO, Gordini L, Marcialis J, Medas F, NICOLOSI, ANGELO, Pisano G   +6 more
core   +1 more source

Genetic dissection reveals distinct contributions of the eS31 N‐terminal domain to translational accuracy in Saccharomyces cerevisiae

The FEBS Journal, EarlyView.
The eukaryote‐specific N‐terminal domain (NTD) of eS31 uses two distinct strategies to maintain translation fidelity. During elongation, a positively charged “hotspot” fine‐tunes the selection of incoming aa‐tRNA. During termination, the entire NTD acts as a structural scaffold to ensure the correct positioning of the release factor eRF1.
Qingxuan Gao, Hiroshi Otsuka, Kei Endo, Koichi Ito   +3 more
wiley   +1 more source

Proteomic analysis of papillary thyroid carcinoma in the context of Hashimoto's thyroiditis. [PDF]

Sci Rep
Zhou H, Tan G, Sun H, Iqbal MA, Zhao Z, Hou J, Moazzam NF, Wang X, Pan D.   +8 more
europepmc   +1 more source

Mind the gap! Extraluminal percutaneous-endoscopic rendezvous with a self-expanding metal stent for restoring continuity in major bile duct injury: A case series [PDF]

, 2019
Bernon, Marc, Burmeister, Sean, Jonas, Eduard, Kloppers, Christo, Lindemann, Jessica   +4 more
core   +2 more sources

Validating the 2022 WHO classification in thyroid carcinomas: Prospective evidence for predicting iodine resistance

Histopathology, EarlyView.
This study assessed the 2022 WHO classification for predicting RAIR disease in thyroid carcinomas, comparing it to older classifications. In a retrospective study of 253 cases, we found the 2022 classification more effective, especially by identifying high‐grade carcinomas and tumour necrosis as critical predictive factors.
Elise André, Laurine Mebarki, Mirela Ilie, Fabien Subtil, Claire Bournaud, Françoise Borson‐Chazot, Françoise Descotes, Jean‐Christophe Lifante, Mireille Bertholon‐Grégoire, Hélène Lasolle, Myriam Decaussin‐Petrucci   +10 more
wiley   +1 more source

A theoretical study of the limits of the acidity of carbon acids in phase transfer catalysis in water and in liquid ammonia

Open Chemistry, 2013
Alkorta Ibon, Elguero José, Gallo Roger
doaj   +1 more source

CD44 is associated with papillary thyroid carcinoma metastasis via potential modulation of the immunosuppressive tumor microenvironment. [PDF]

Clin Exp Med
Adeerjiang Y, Huo MH, Ma L, Li XX, Tian Y, Bai C, Wang BW, Qu X, Yao XY, Ma LL, Gan XX, Kuang JY, Liang HZ, Qiang BR, Wang R, Bao JL, Jiang S, Du GL.   +17 more
europepmc   +1 more source

Glomerular plasmalemma vesicle‐associated protein‐1 as an endothelial remodelling marker complementing C4d in chronic active antibody‐mediated rejection

Histopathology, EarlyView.
Glomerular plasmalemma vesicle‐associated protein‐1 (PV‐1/PLVAP) identifies dynamic endothelial remodelling in chronic active antibody‐mediated rejection (caABMR), complementing glomerular C4d, which reflects a static footprint of complement activation. Combined assessment of PV‐1 and C4d captures complementary dimensions of microvascular pathology and
Yuto Igarashi, Mayu Shimokawa, Kunio Kawanishi, Toshihito Hirai, Hiroshi Seino, Tomokazu Shimizu, Hideki Ishida, Toshio Takagi   +7 more
wiley   +1 more source

Diagnostic accuracy in BRAF V600E-negative papillary thyroid cancer via 5-gene expression profiling of residual nucleic acids from mutation testing: a retrospective study. [PDF]

BMC Cancer
Wang L, Mao W, Deng H, Zhou WP, Zhang L, Li J.   +5 more
europepmc   +1 more source